✦ LIBER ✦

A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia

✍ Scribed by Jun Sasaki; Kikuo Arakawa; Kyosuke Yamamoto; Shozo Kobori; Masato Ageta; Suminori Kono

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of cerivastatin sodium, a new HM

✍ Susumu Tazuma; Gunji Yamashita; Hidenori Ochi; Hiroyuki Miura; Tsuyoshi Kajihara 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Long-term effects of NK-104 (itavastatin

✍ H Mabuchi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Long-term treatment with pitavastatin (N

✍ Yoshihiro Noji; Toshinori Higashikata; Akihiro Inazu; Atsushi Nohara; Kosei Ueda 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Cerivastatin, a new synthetic HMG CO-A r

✍ V.V. Kukharchuk; E.Yu. Solovieva; T.A. Rozhkova; M.G. Tvorogova 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Atorvastatin, a New HMG-CoA Reductase In

✍ Isaacsohn, J. L.; Bakker-Arkema, R. G.; Fayyad, R.; Whitcomb, R.; Black, D. M. 📂 Article 📅 1997 🏛 SAGE Publications 🌐 English ⚖ 560 KB

Pharmacodynamics of new HMG-CoA reductas

✍ A.G Olsson; J.S Pears; J McKellar; R.J Caplan; A Raza 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 137 KB